ToPCaP

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer.

Crawley D, Garmo H, Rudman S, Stattin P, Haggstrom C, Zethelius B, Holmberg L, Adolfsson J, Van Hemelrijck M. Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer. Int J Cancer (2016): In press.